SCHEMBL20350899

SCHEMBL20350899

CCSc1[nH]c(=O)c(C)c(C(F)(F)F)c1C#N

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.39
▸ HPGD P15428 7/20 0.39
▸ KDM4E B2RXH2 6/20 0.39
▸ GAA P10253 5/20 0.39
▸ GLA P06280 4/20 0.39
▸ TP53 P04637 1/20 0.39
▸ POLB P06746 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ ATM Q13315 2/20 0.34
▸ MAPT P10636 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.32
▸ HSD11B1 P28845 2/20 0.32
▸ CXCR2 P25025 1/20 0.32
▸ GFER P55789 1/20 0.32
▸ UPP1 Q16831 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20340026 0.87 ALDH1A1 (0.40) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20340117 0.84 KDM4E (0.57) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20350879 0.82 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20350844 0.79 KDM4E (0.39) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20340086 0.78 HSD11B1 (0.33) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20350871 0.77 KDM4E (0.38) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20340085 0.74 KDM4E (0.44) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20339960 0.71 KDM4E (0.38) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL23183403 0.71 KDM4E (0.32) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL20340035 0.70 KDM4E (0.61) ALDH1A1HPGDKDM4EGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018125983-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS MITOBRIDGE, INC. (US) 2018-07-05 — — WO disclosed
Send feedback